2007

Joint Statement from Drs. Elias Zerhouni, Jack Whitescarver, and Anthony Fauci of the National Institutes of Health on World AIDS Day - NIH Announces 2007 World AIDS Day Award Recipients
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - November 30, 2007
On December 1, people around the globe will commemorate World AIDS Day. More than 25 million men, women and children have already died, and an estimated 33.2 million people around the world are currently living with HIV infection. Each day, another 6,800 people become infected. Last year alone, an estimated 2.5 million


NIDA ANNOUNCES NEW AVANT-GARDE AWARD FOR INNOVATIVE AIDS RESEARCH
U.S. Department of Health and Human Services; National Institutes of Health; NIH News; National Institute on Drug Abuse (NIDA) - Tuesday, November 27, 2007
Contact: Dorie Hightower or Sara Rosario Wilson, 301-443-6245, , Contacto en Espaņol: 301-594-6145
Award intended to stimulate scientists of exceptional creativity to study concepts and approaches in the forefront of drug abuse and HIV/AIDS research The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), announced today it is looking for scientists of exceptional creativity to a


NIH Hosts Event to Launch Council of Science Editors' Global Theme Issue: More than 230 journals worldwide examine research related to poverty and human development
U.S. Department of Health and Human Services; National Institutes of Health; NIH News; John E. Fogarty International Center (FIC) - Monday, October 22, 2007
CONTACT: Ann Puderbaugh, 301-496-2075,
The National Institutes of Health today is hosting the launch of the Council of Science Editors global theme issue on poverty and human development, to coincide with the publication of related research by more than 230 journals worldwide. Seven of the most outstanding articles examining interventions and projects to im


STATEMENT: Immunizations Are Discontinued in Two HIV Vaccine Trials
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - Friday, September 21, 2007
Media Contact: NIAID News and Public Information Branch, (301) 402-1663, niaidnews@niaid.nih.gov
An independent Data and Safety Monitoring Board (DSMB) met this week to review interim data from a large, international HIV vaccine clinical trial known as the STEP study -- also referred to as the HVTN 502 or Merck V520-023 study. The clinical trial, which began enrolling volunteers in December 2004, is co-sponsored b


Anthony S. Fauci Awarded Lasker Award for Public Service
National Institutes Of Health - September 15, 2007
Contact: Patricia Conrad
Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), has been awarded the 2007 Mary Woodard Lasker Award for Public Service for his role in developing two major U.S. public health programs, in AIDS and biodefense. The award wil


HIV Protease Inhibitors Show Potential as Cancer Treatments
U.S. Department of Health and Human Services; National Institutes Of Health: NIH News: National Cancer Institute (NCI) - Saturday, September 1, 2007
CONTACT: NCI Press Officers, , 301-496-6641
Several protease inhibitors that are used in combination with other drugs to treat Human Immunodeficiency Virus (HIV) infection may also be effective against certain types of cancer, according to researchers from the National Cancer Institute (NCI), part of the National Institutes of Health. Nelfinavir (


Study Sheds New Light on Intimate Lives of Older Americans: Older Adults Are Active Despite Increased Sexual Problems with Age
U.S. Department of Health and Human Services; National Institutes of Health; NIH News; National Institute on Aging (NIA) - Wednesday, August 22, 2007
CONTACT: Linda Joy or Susan Farrer, 301-496-1752,
A majority of older Americans are sexually active and view intimacy as an important part of life, despite a high rate of bothersome sexual problems, according to a new report in the Aug. 23, 2007, issue of The New England Journal of Medicine . The findings come from the National Social Life, Health and Aging Project, r


NCRR LAUNCHES NATIONAL NETWORK TO CONNECT INVESTIGATORS BASED AT MINORITY INSTITUTIONS: Award Will Facilitate Multi-Site Collaborative Clinical and Translational Research
U.S. Department of Health and Human Services; National Institutes of Health; NIH News; National Institute of General Medical Sciences (NIGMS); National Center on Minority Health and Health Disparities (NCMHD) - Tuesday, July 24, 2007
CONTACT: Lori Mulligan, 301-435-0897,
The National Center for Research Resources (NCRR), a part of the National Institutes of Health (NIH), announced today it will initially provide $9.5 million over three years to launch a Translational Research Network that will increase the opportunity for multi-site clinical and translational research among minority an


A Brief Skill-Building Program Can Reduce Std or HIV Risk Among Inner-City African American Women
U.S. Department of Health and Human Services; National Institutes of Health; NIH News; National Institute of Nursing Research (NINR) - Tuesday, June 26, 2007
CONTACT: Ray Bingham, 301-594-8011, e-mail:binghamr@mail.nih.gov
A brief skill-building program on practices to reduce exposure to sexually transmitted disease (STD) and HIV improved the self-reported protective behaviors of inner-city black women for up to one year and actually decreased their risk of acquiring an STD, according to a study appearing in the June 2007 issue of the Am


HEALTH OFFICIALS RENEW INDO-U.S. VACCINE ACTION PROGRAM
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - Tuesday, May 8, 2007
CONTACT: Sitara Maruf, 301-402-1663, e-mail: marufs@niaid.nih.gov
U.S. and Indian health officials have renewed the Indo-U.S. Vaccine Action Program (VAP), a 20-year-old bilateral collaboration supporting research on vaccines, immunology and related biomedical issues. The VAP aims to reduce the burden of vaccine-preventable diseases of public health significance in India, the


NIDA LOOKS AT NON-INJECTION DRUG USE AND SPREAD OF HIV/AIDS: CDC estimates 250,000 Americans Unaware they are HIV-Positive
U.S. Department of Health and Human Services; National Institutes Of Health, NIH News; National Institute on Drug Abuse (NIDA) - Tuesday, May 8, 2007
CONTACT: Dorie Hightower or Sara Rosario Wilson, 301-443-6245, e-mail: media@nida.nih.gov, Contacto en Espanol: 301-594-6145
More than 500 scientists, clinicians and public health specialists met today at the National Institutes of Health (NIH) to discuss the latest research on drug abuse and the evolving epidemic of HIV/AIDS. This is the first-ever two-day public meeting at NIH to include a focus on non-injection drug use and HIV transmissi


Imaging Techniques Reveal That HIV Infects Host Cells Using A Molecular Entry Claw
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; National Cancer Institute (NCI) - Thursday, May 3, 2007
CONTACT: NCI Office of Media Relations, 301-496-6641,
An advanced imaging technique known as electron tomography has allowed researchers at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to visualize an entry claw, a unique structure formed between the human immunodeficiency virus (HIV) that causes AIDS and the cell it infects. The f


Anthony S. Fauci Awarded The Highest Honor Of The Association Of American Physicians
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - Sunday, April 15, 2007
CONTACT: NIAID News Office, 301-402-1663,
Immunologist and AIDS researcher Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH), has been awarded the 2007 George M. Kober Medal of the Association of American Physicians (AAP) for his outstanding contributions to academic


ANALYSIS OF RHESUS MONKEY GENOME UNCOVERS GENETIC DIFFERENCES WITH HUMANS, CHIMPS DNA Comparison Provides New Clues to Primate Biology
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; National Human Genome Research Institute (NHGRI) - Thursday, April 12, 2007
CONTACT: Geoff Spencer, 301-402-0911,
An international consortium of researchers has published the genome sequence of the rhesus macaque monkey and aligned it with the chimpanzee and human genomes. Published April 13 in a special section of the journal Science , the analysis reveals that the three primate species share about 93 percent of their DNA, yet ha


NIDA Meeting to Look at Drug-Impaired Decision-Making and HIV Transmission: One of First-Ever NIH Meetings to Examine the Role between Non-Injection Drug Use and HIV/AIDS
National Institutes Of Health - April 4, 2007
CONTACT: Dorie Hightower or Sara Rosario Wilson, 301-443-6245
The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), is holding a two day meeting to explore wide-ranging issues related to drug abuse, impaired decision making, and HIV/AIDS. Drug Abuse and Risky Behaviors: The Evolving Dynamics of HIV/AIDS will provide a broad understanding of


NIH AND INSTITUT PASTEUR EXTEND COLLABORATION AGREEMENT FOR HIV-1 DIAGNOSTICS
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; NIH Office of the Director (OD); NIH Office Of Technology Transfer (OTT)- Tuesday, April 3, 2007
CONTACT: Mark Rohrbaugh, 301-594-7700, , Alain Guedon, Institut Pasteur, EVP Business Development, +33672754162
The National Institutes of Health (NIH), an agency of the U.S. Department of Health and Human Services, and Institut Pasteur (IP), a private non-profit foundation, announced today an agreement to extend their long-standing collaboration in health research and the management of inventions arising from this research. The


SCIENTISTS SEQUENCE GENOME OF PARASITE RESPONSIBLE FOR COMMON SEXUALLY TRANSMITTED INFECTION
U.S. Department of Health and Human Services; National Institutes Of Health; NIH News; National Institute of Allergy and Infectious Diseases (NIAID) - Thursday, January 11, 2007
CONTACT: Kathy Stover, 301-402-1663, e-mail: kstover@niaid.nih.gov
Researchers have decoded the genetic makeup of the parasite that causes trichomoniasis, one of the most common sexually transmitted infections (STIs), revealing potential clues as to why the parasite has become increasingly drug resistant and suggesting possible pathways for new treatments, diagnostics and a potential


WOMEN'S RESPONSE TO ANTI-HIV THERAPY IMPROVED IF TREATMENT BEGINS SIX MONTHS AFTER EARLIER PREVENTIVE REGIMEN: Response to Treatment Diminished If Treatment Begins Within Six Months Of Preventive Regimen
National Institutes Of Health; National Institute of Child Health and Human Development (NICHD); Fogarty International Center (FIC) - Wednesday, January 10, 2007
Robert Bock or Marianne Glass Miller, 301-496-5133, e-mail: bockr@mail.nih.gov
A woman s response to HIV treatment with drug combinations that contain nevirapine is improved if at least six months have passed after she received the drug as a single dose during labor to prevent passing HIV on to her child. (The response to treatment is measured by the reduction of HIV in the blood.) Conversely



This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1980, 2007. AEGiS.